AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Research

NIH’s Dr. Jack Whitescarver Honored with New IAS Presidential Award for His Outstanding Commitment to the Global Fight Against HIV

Dr. Anthony Fauci, Dr. Julio Montaner and Dr. Jack Whitescarver

Today, the International AIDS Society (IAS) honored Dr. Jack Whitescarver, Associate Director for AIDS Research of the National Institutes of Health (NIH) and Director of the NIH Office of AIDS Research, for his outstanding commitment to the global fight against HIV, and his pioneering work in the field. During the closing session of the XVIII…

XVIII International AIDS Conference

Kevin Fenton: Health Protection Perspectives

Greetings from the XVIII International AIDS Conference in Vienna! It is invigorating to once again be among the more than 20,000 HIV/AIDS scientists, public health officials, advocates, and front-line workers in the fight against this disease. The International AIDS Conference always provides a platform for the world’s HIV/AIDS leaders to share the latest information and…

IAC Day 4: Malignancies and People Living with HIV/AIDS

Dr. Valdiserri at work at IAC

Today at the International AIDS Conference  meeting, researchers from the United States, France, Canada, and Romania presented findings on the important clinical topic of malignancies that can develop in people with HIV/AIDS. Scientists from the U.S. National Cancer Institute reported that the rates of so-called “AIDS-defining malignancies,” like Kaposi’s sarcoma and non-Hodkgin lymphoma (NHL), have…

International AIDS Conference Day 3: Research Highlights

Dr. Ron Valdiserri

Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, shared the latest scientific information with the conference delegates about the actual steps that the human immunodeficiency virus (HIV) takes when it makes contact with the human genital tract (through exposure to semen or vaginal secretions) which result in infection.Understanding, in detail,…

Dr. Anthony S. Fauci’s Statement on the CAPRISA 004 Microbicide Study

Dr. Anthony Fauci

On July 19, 2010, Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, released a statement to acknowledge the results from the CAPRISA 004 Microbicide Study. To read the entire statement, visit the NIAID website. “Today we congratulate the Centre for the AIDS Programme of Research in…

Future Directions for NIAID’s HIV Vaccine Clinical Research

Future Directions for NIAID HIV Research

Co-authored by Margaret I. Johnston, Ph.D., Director of the Vaccine Research Program in NIAID’s Division of AIDS Carl W. Dieffenbach, PhD Margaret I. Johnston, PhD The development of a safe and effective preventive vaccine for HIV remains one of NIAID’s highest priorities. As we look to the future, we are also seeking to expand the…

Looking Ahead: NIAID’s Future HIV/AIDS Therapeutics Priorities

Future Directions for NIAID HIV Research

Since the 1980s when the HIV/AIDS epidemic was first recognized, NIAID-supported clinical research has helped to save millions of lives and played a key role in defining the standard of care for treating HIV infection. This blog post describes what we are seeking for the next wave of HIV/AIDS therapeutic approaches. Specifically, we have identified…

Future Priorities for NIAID’s HIV Prevention Research

Future Directions for NIAID HIV Research

As we begin to discuss the restructuring of NIAID’s clinical trials networks, let us first focus on the Institute’s HIV prevention research agenda. Developing new biomedical tools that can safely and effectively prevent HIV acquisition and transmission is critical to addressing the global HIV/AIDS pandemic. Currently, we are exploring several promising HIV prevention strategies that,…